81 related articles for article (PubMed ID: 2788545)
1. Serum levels of soluble Tac peptide in acute and chronic hepatitis B virus infection.
Chu CM; Liaw YF
Clin Immunol Immunopathol; 1989 Oct; 53(1):52-8. PubMed ID: 2788545
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis.
Alberti A; Chemello L; Fattovich G; Pontisso P; Semenzato G; Colletta C; Vinante F; Pizzolo G
Dig Dis Sci; 1989 Oct; 34(10):1559-63. PubMed ID: 2507263
[TBL] [Abstract][Full Text] [Related]
3. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
[TBL] [Abstract][Full Text] [Related]
4. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
6. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.
Hoofnagle JH; Dusheiko GM; Seeff LB; Jones EA; Waggoner JG; Bales ZB
Ann Intern Med; 1981 Jun; 94(6):744-8. PubMed ID: 7235415
[TBL] [Abstract][Full Text] [Related]
7. The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study.
Lai ME; Solinas A; Mazzoleni AP; Deplano A; Farci P; Lisci V; Porru A; Tocco A; Balestrieri A
J Hepatol; 1994 Jun; 20(6):773-81. PubMed ID: 7930478
[TBL] [Abstract][Full Text] [Related]
8. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood.
Bortolotti F; Cadrobbi P; Crivellaro C; Guido M; Rugge M; Noventa F; Calzia R; Realdi G
Gastroenterology; 1990 Sep; 99(3):805-10. PubMed ID: 2379783
[TBL] [Abstract][Full Text] [Related]
10. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble CD30 in chronic hepatitis B virus infection.
Fattovich G; Vinante F; Giustina G; Morosato L; Alberti A; Ruol A; Pizzolo G
Clin Exp Immunol; 1996 Jan; 103(1):105-10. PubMed ID: 8565268
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
14. IgM antibody to hepatitis B core antigen in children with chronic type B hepatitis.
Bortolotti F; Bertaggia A; Rude L; Armigliato M; Crivellaro C; Alberti A; Pornaro E; Realdi G
Eur J Pediatr; 1987 Jul; 146(4):394-7. PubMed ID: 3653136
[TBL] [Abstract][Full Text] [Related]
15. Impaired interleukin-2 receptor expression on lymphocytes from patients with chronic active hepatitis type B.
Ahn DS; Jang HC; Ahn JK; Yim CY; Kim DG
Korean J Intern Med; 1989 Jan; 4(1):34-40. PubMed ID: 2487403
[TBL] [Abstract][Full Text] [Related]
16. [Natural history of the state of asymptomatic carrier of HBsAg: 7-year follow-up].
Antoniozzi F; Meucci G; Vecchi M; Ronchi G; Collatina R; Del Ninno E; de Franchis R
Boll Ist Sieroter Milan; 1986; 65(5):347-53. PubMed ID: 3828089
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathophysiological aspects of chronic active hepatitis.
Iwamura K
Tokai J Exp Clin Med; 1986; 11 Suppl():147-57. PubMed ID: 3452239
[TBL] [Abstract][Full Text] [Related]
18. Serological and histological follow up of chronic hepatitis B infection.
Ruiz-Moreno M; Camps T; Aguado JG; Porres JC; Oliva H; Bartolomé J; Carreño V
Arch Dis Child; 1989 Aug; 64(8):1165-9. PubMed ID: 2782931
[TBL] [Abstract][Full Text] [Related]
19. Serum soluble interleukin-2 receptor levels in patients with chronic hepatitis B virus infection and its relation with anti-HBc.
Xiao P; Chen QF; Yang YL; Guo ZH; Chen H
World J Gastroenterol; 2006 Jan; 12(3):482-4. PubMed ID: 16489655
[TBL] [Abstract][Full Text] [Related]
20. [Clinical importance of hepatitis B virus DNA detection in serum of children with chronic hepatitis B].
Wirth S; Möllers U; Schaefer E; Schwarze U; Zabel B
Klin Padiatr; 1992; 204(3):155-7. PubMed ID: 1614181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
